Top Markets
Coin of the day
GemVax&KAEL Co.,Ltd GemVax&KAEL Co.,Ltd

GemVax&KAEL Co.,Ltd

082270
Rank in Stocks #15776
GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration... GemVax & KAEL Co., Ltd. specializes in manufacturing chemical filtration systems and gas purification units, primarily for the semiconductor industry. The company operates through two main segments: Environmental Pollution Control and Bio Business. Its Environmental Pollution Control division focuses on creating essential filters for semiconductor and display fabrication processes, in addition to developing equipment for air quality management and odor prevention. Concurrently, the Bio Business division is dedicated to advancing its innovative telomerase-derived peptide drug, GV1001, through preparations for domestic and international Phase 2 and 3 clinical trials. These trials are designed to address various conditions, including Alzheimer's disease, benign prostatic hyperplasia, and progressive supranuclear palsy. Founded on March 10, 1998, GemVax & KAEL Co., Ltd. is headquartered in Daejeon, South Korea.
Share Price
$7.54
Market Cap
$331.60M
Change (1 day)
-3.79%
Change (1 year)
-75.66%
Country
KR
Trade GemVax&KAEL Co.,Ltd (082270)

Category

Stock price history for GemVax&KAEL Co.,Ltd (082270)
Highest end of day price: $7.54 on 2026-09-01

Lowest end of day price: $6.98 on 2005-06-01
Stock price history of GemVax&KAEL Co.,Ltd from 2005 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 3.21%
2025 88.44%
2024 8.58%
2023 1.92%
2022 -33.81%
2021 -30.60%
2020 -25.31%
2019 163.75%
2018 -18.47%
2017 20.91%
2016 -44.19%
2015 31.29%
2014 23.84%
2013 -61.74%
2012 -4.64%
2011 196.44%
2010 103.86%
2009 147.53%
2008 -42.84%
2007 -19.82%
2006 -33.32%
2005 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$297.13 -
US
$330.64 18.03%
DE
$341.49 38.69%
FR
$166.56 58.69%
DE
$952.71 25.46%
US